Functional Properties of Oligomeric and Monomeric Forms of Helicobacter pylori VacA Toxin.
bacterial protein toxin
bacterial toxins
gastric cancer
membrane channel proteins
membrane channels
oligomerization
pore-forming proteins
pore-forming toxins
Journal
Infection and immunity
ISSN: 1098-5522
Titre abrégé: Infect Immun
Pays: United States
ID NLM: 0246127
Informations de publication
Date de publication:
16 11 2021
16 11 2021
Historique:
pubmed:
21
9
2021
medline:
15
12
2021
entrez:
20
9
2021
Statut:
ppublish
Résumé
Helicobacter pylori VacA is a secreted toxin that assembles into water-soluble oligomeric structures and forms anion-selective membrane channels. Acidification of purified VacA enhances its activity in cell culture assays. Sites of protomer-protomer contact within VacA oligomers have been identified by cryoelectron microscopy, and in the current study, we validated several of these interactions by chemical cross-linking and mass spectrometry. We then mutated amino acids at these contact sites and analyzed the effects of the alterations on VacA oligomerization and activity. VacA proteins with amino acid charge reversals at interprotomer contact sites retained the capacity to assemble into water-soluble oligomers and retained cell-vacuolating activity. Introduction of paired cysteine substitutions at these sites resulted in formation of disulfide bonds between adjacent protomers. Negative-stain electron microscopy and single-particle two-dimensional class analysis revealed that wild-type VacA oligomers disassemble when exposed to acidic pH, whereas the mutant proteins with paired cysteine substitutions retain an oligomeric state at acidic pH. Acid-activated wild-type VacA caused vacuolation of cultured cells, whereas acid-activated mutant proteins with paired cysteine substitutions lacked cell-vacuolating activity. Treatment of these mutant proteins with both low pH and a reducing agent resulted in VacA binding to cells, VacA internalization, and cell vacuolation. Internalization of a nonoligomerizing mutant form of VacA by host cells was detected without a requirement for acid activation. Collectively, these results enhance our understanding of the molecular interactions required for VacA oligomerization and support a model in which toxin activity depends on interactions of monomeric VacA with host cells.
Identifiants
pubmed: 34543122
doi: 10.1128/IAI.00348-21
pmc: PMC8594603
doi:
Substances chimiques
Bacterial Proteins
0
Bacterial Toxins
0
VacA protein, Helicobacter pylori
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0034821Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK058404
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI138932
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI112541
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA116087
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI118932
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA068485
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI039657
Pays : United States
Organisme : BLRD VA
ID : I01 BX004447
Pays : United States
Références
Infect Immun. 2008 Jul;76(7):2843-51
pubmed: 18443094
J Biol Chem. 1995 Jul 28;270(30):17771-7
pubmed: 7629077
Cell Host Microbe. 2018 May 9;23(5):583-593.e8
pubmed: 29746831
Mol Microbiol. 2000 Jul;37(2):433-42
pubmed: 10931337
Biochemistry. 2010 Jul 13;49(27):5743-52
pubmed: 20527875
Mol Microbiol. 1994 Apr;12(2):307-19
pubmed: 8057855
Gastroenterology. 2017 Aug;153(2):420-429
pubmed: 28456631
J Cell Biol. 1997 Aug 25;138(4):759-69
pubmed: 9265644
J Struct Biol. 2005 Sep;151(3):215-28
pubmed: 16125415
J Mol Biol. 2013 Feb 8;425(3):524-35
pubmed: 23178866
J Biol Chem. 2002 Sep 13;277(37):34642-50
pubmed: 12121984
Toxins (Basel). 2016 Jun 18;8(6):
pubmed: 27322323
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6800-6805
pubmed: 30894496
Gastroenterology. 2009 May;136(6):1863-73
pubmed: 19457415
J Mol Biol. 2002 Apr 19;318(1):121-33
pubmed: 12054773
Infect Immun. 2016 Aug 19;84(9):2662-70
pubmed: 27382020
Annu Rev Pathol. 2021 Jan 24;16:123-144
pubmed: 33197219
Mol Biol Cell. 2005 Oct;16(10):4852-66
pubmed: 16055501
J Biol Chem. 1999 Apr 2;274(14):9277-82
pubmed: 10092603
J Proteome Res. 2010 Apr 5;9(4):1716-26
pubmed: 20131910
Infect Immun. 2001 Feb;69(2):730-6
pubmed: 11159961
J Biol Chem. 2003 Apr 4;278(14):12101-8
pubmed: 12562777
J Am Soc Mass Spectrom. 2012 Jan;23(1):76-87
pubmed: 22038510
J Biol Chem. 1999 Dec 31;274(53):37736-42
pubmed: 10608833
Gastroenterology. 1999 Apr;116(4):823-30
pubmed: 10092304
Sci Rep. 2020 Jun 9;10(1):9307
pubmed: 32518315
Infect Immun. 2019 Mar 25;87(4):
pubmed: 30692181
J Struct Biol. 2015 Nov;192(2):216-21
pubmed: 26278980
Biochem Biophys Res Commun. 1998 Jul 20;248(2):334-40
pubmed: 9675136
BMC Microbiol. 2010 Feb 23;10:60
pubmed: 20178613
Nat Microbiol. 2019 Aug;4(8):1411-1423
pubmed: 31110360
J Bacteriol. 2001 Nov;183(22):6499-508
pubmed: 11673417
Toxins (Basel). 2016 Jun 03;8(6):
pubmed: 27271669
J Biol Chem. 1994 Apr 8;269(14):10566-73
pubmed: 8144644
Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16293-8
pubmed: 17911250
J Biol Chem. 2008 Sep 26;283(39):26714-25
pubmed: 18625712
Toxins (Basel). 2017 Oct 12;9(10):
pubmed: 29023421
J Mol Biol. 2019 May 3;431(10):1956-1965
pubmed: 30954575
PLoS Pathog. 2008 May 23;4(5):e1000073
pubmed: 18497859
mBio. 2016 Jan 26;7(1):e01869-15
pubmed: 26814181
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):3047-52
pubmed: 23382221
Nat Rev Microbiol. 2005 Apr;3(4):320-32
pubmed: 15759043
J Natl Cancer Inst. 2002 Nov 20;94(22):1680-7
pubmed: 12441323
Toxins (Basel). 2016 Jun 16;8(6):
pubmed: 27322319
FEBS Lett. 1999 Apr 30;450(1-2):101-4
pubmed: 10350065
J Biol Chem. 1995 Oct 13;270(41):23937-40
pubmed: 7592587
J Biol Chem. 1992 May 25;267(15):10570-5
pubmed: 1587837
Cancer Res. 1995 May 15;55(10):2111-5
pubmed: 7743510
J Biol Chem. 2005 Jun 3;280(22):21107-14
pubmed: 15817461
Front Cell Infect Microbiol. 2012 Mar 27;2:37
pubmed: 22919629
Infect Immun. 2006 Mar;74(3):1786-94
pubmed: 16495552
Elife. 2013 Sep 10;2:e01456
pubmed: 24040512
J Struct Biol. 2005 Jul;151(1):41-60
pubmed: 15890530
Commun Biol. 2019 Jun 19;2:218
pubmed: 31240256
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5024-9
pubmed: 15044704
Int J Cancer. 2015 Jan 15;136(2):487-90
pubmed: 24889903
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2001-6
pubmed: 10051584
Infect Immun. 1991 Apr;59(4):1264-70
pubmed: 2004808
Mol Microbiol. 2016 Oct;102(1):22-36
pubmed: 27309820
J Biol Chem. 1999 Dec 17;274(51):36693-9
pubmed: 10593974
J Natl Cancer Inst. 2007 Sep 5;99(17):1328-34
pubmed: 17728213
J Allergy Clin Immunol. 2019 Apr;143(4):1496-1512.e11
pubmed: 30240703
Infect Immun. 2018 Apr 23;86(5):
pubmed: 29531133
mBio. 2019 Mar 19;10(2):
pubmed: 30890606
Front Microbiol. 2010 Nov 23;1:115
pubmed: 21687723
EMBO J. 1999 Oct 15;18(20):5517-27
pubmed: 10523296
J Exp Med. 1994 May 1;179(5):1653-58
pubmed: 8163943
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701